Margaret A. Tucker | |
---|---|
![]() | |
Alma mater | Wellesley College Harvard Medical School |
Awards | Public Health Service Distinguished Service Medal |
Scientific career | |
Fields | Oncology, genetic epidemiology |
Institutions | National Cancer Institute |
Margaret Anne Tucker is an American oncologist and physician-scientist specialized in environmental and genetic epidemiology, familial cancers, and melanomas. She is a scientist emeritia at the National Cancer Institute (NCI). Tucker was a commissioned officer in the United States Public Health Service Commissioned Corps and served as director of the NCI human genetics program from 2005 until her retirement in June 2018.
Margaret A. Tucker completed a bachelor's degree at Wellesley College. [1] She earned a M.D. from the Harvard Medical School and completed training in internal medicine and medical oncology at Stanford University Medical Center. [2]
Tucker joined the National Institutes of Health (NIH) in 1978 as a commissioned officer in the United States Public Health Service Commissioned Corps (PHSCC). [1] She served as chief of the family studies section of the environmental epidemiology branch from 1987 to 1992, chief of the genetic epidemiology branch (GEB) from 1992 to 2011, and director of the human genetics program from 2005 until her retirement in June 2018. [1] Tucker was the acting director of the division of cancer epidemiology and genetics DCEG between 2012 and 2013. [1] She is a recipient of a Public Health Service Distinguished Service Medal. [1] During her tenure at the National Cancer Institute (NCI), Tucker led the Institute’s research program on familial cancers. [2] Tucker's scientific contributions have improved our understanding of the mechanisms underlying familial cancers, the etiology of melanoma, and predisposition to multiple malignancies. [2] Her research team and collaborators identified the first major susceptibility genes for melanoma. [2] Tucker and her team published a melanoma atlas, created training videos for the clinical examination of members of high-risk families, developed the first calculator to estimate an individual’s risk of developing melanoma, and more launched a website with the first-ever serial collection of dysplastic nevi and melanomas, documenting skin changes over nearly four decades of clinical follow-up. [2] Tucker retired in June 2018 and was named as a scientist emerita by the National Institutes of Health (NIH) scientific directors. [2]
Louise A. Brinton is an American epidemiologist. She was a senior investigator, Chief of the Hormonal and Reproductive Epidemiology Branch, and the first Scientific Advisor for International Activities of the National Cancer Institute Division of Cancer Epidemiology and Genetics.
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Martha S. Linet is an American physician epidemiologist. She is a scientist emerita at the National Cancer Institute (NCI). Linet retired in January 2020 after 33 years at NCI. She was a senior investigator and branch chief in the NCI radiation epidemiology branch. Linet specialized in epidemiology, the etiology of pediatric and adult leukemia, lymphoma, and brain tumors, as well as the health effects of ionizing and non-ionizing radiation and benzene exposure.
Ruth A. Kleinerman is an American epidemiologist specialized in retinoblastoma. Kleinerman worked at the National Cancer Institute (NCI) from 1979 to 2019 where she served as a staff scientist and deputy chief of the Radiation Epidemiology Branch.
Katrina A. Blouke Goddard is an American genetic epidemiologist and biostatistician specializing in public health genomics and the translation of genomic applications into clinical practice. Goddard is the director of the division of cancer control and population sciences (DCCPS) at the National Cancer Institute (NCI). She was previously the distinguished investigator and director of translational and applied genomics at the Kaiser Permanente Center for Health Research and a faculty member at Case Western Reserve University.
Sharon A. Savage is an American pediatric hematologist/oncologist. She is the clinical director of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
Jennifer T. Loud is an American nurse practitioner who served as the assistant chief of the National Cancer Institute's clinical genetics branch until August 2020.
Rachael Z. Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.
Laura Elizabeth Beane Freeman is an American environmental epidemiologist who is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
Debra Toby Silverman is an American biostatistician and epidemiologist specialized in bladder cancer epidemiology and the carcinogenicity of diesel exhaust. Silverman is the chief of the occupational and environmental epidemiology branch at the National Cancer Institute.
Shelia Hoar Zahm is an American cancer epidemiologist specialized in pesticides and cancer, the etiology of non-Hodgkin lymphoma, and occupational cancer among women. She was deputy director of the National Cancer Institute's division of cancer epidemiology and genetics from 1998 to 2011.
Patricia A. Hartge is an American cancer epidemiologist who conducted genome-wide association studies on ovarian cancer, non-Hodgkin lymphoma, melanoma, and other malignancies. From 1996 to 2013, Hartge was deputy director of the epidemiology and biostatistics program in the division of cancer epidemiology and genetics at the National Cancer Institute.
Hannah P. Yang is an American cancer epidemiologist who is a staff scientist and associate director of scientific operations in the National Cancer Institute's division of cancer epidemiology and genetics.
Mia M. Gaudet is an American molecular epidemiologist pectized in cancer prevention research and managing cohort studies. She is a senior scientist in the division of cancer epidemiology and genetics at the National Cancer Institute.
Jill Suzanne Barnholtz-Sloan is an American biostatistician and data scientist specialized in cancer epidemiology and etiologic investigations of brain tumors. She is a senior investigator and associate director for informatics and data science at the National Cancer Institute.
Maria Teresa Landi is an Italian epidemiologist and oncologist who researches genetic and environmental determinants of lung cancer and melanoma. At the National Cancer Institute, she is a senior investigator in the integrative tumor epidemiology branch and a senior advisor for genomic epidemiology. Landi is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Ruth Maria Pfeiffer is a biostatistician whose research focuses on risk prediction, molecular and genetic epidemiology, and electronic medical records. She is a senior investigator in the biostatistics branch at the National Cancer Institute. Pfeiffer is an elected member of the International Statistical Institute and the American Statistical Association.
Mitchell H. Gail is an American physician-scientist and biostatistician. He is a distinguished investigator at the National Cancer Institute.
Shahinaz Mohamed Aly Gadalla is a physician-scientist and cancer epidemiologist who researches cancer biomarkers and hematopoietic stem cell transplantation. She is a senior investigator in the clinical genetics branch at the National Cancer Institute.
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.